Klotz, Laurence. “Sunitinib, Sorafenib and Other Systemic Noncytotoxic Kidney Cancer Therapies Can and Should Be Administered by Urologists”. Canadian Urological Association Journal 1, no. 2S (December 11, 2012). Accessed May 5, 2026. https://cuaj.ca/index.php/journal/article/view/70.